BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10092710)

  • 1. Radiation therapy for benign disease of the orbit.
    Smitt MC; Donaldson SS
    Semin Radiat Oncol; 1999 Apr; 9(2):179-89. PubMed ID: 10092710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy of lymphoid diseases of the orbit.
    Austin-Seymour MM; Donaldson SS; Egbert PR; McDougall IR; Kriss JP
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):371-9. PubMed ID: 3918966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of radiation therapy in benign ocular diseases.
    Mod H; Jha AK
    J Nepal Health Res Counc; 2014; 12(27):130-7. PubMed ID: 25575007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic neuropathy following orbital irradiation for Graves' ophthalmopathy: a case report and literature review.
    Sánchez-Orgaz M; Grabowska A; Royo-Oreja A; Asencio-Durán M; Romero-Martín R; Arbizu-Duralde A
    Orbit; 2012 Feb; 31(1):30-3. PubMed ID: 22029640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
    Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
    Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
    Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
    Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
    Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ
    Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital Radiation Therapy in Thyroid Eye Disease.
    Chundury RV; Weber AC; Perry JD
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):83-9. PubMed ID: 26325378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.
    Harnett AN; Doughty D; Hirst A; Plowman PN
    Br J Ophthalmol; 1988 Apr; 72(4):289-92. PubMed ID: 3259894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
    Petersen IA; Kriss JP; McDougall IR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.